In this commentary, Sandra P. D’Angelo, MD, highlights the practice-changing use of immune checkpoint inhibitor therapy for the treatment of patients with metastatic Merkel cell carcinoma.
In this commentary Shailender Bhatia, MD, shares his perspective on the unprecedented efficacy of immunotherapy in treating a patient with bulky metastatic MCC.
In this commentary, Howard L. Kaufman, MD, highlights practice-changing clinical trial results on avelumab, the first FDA-approved treatment for metastatic Merkel cell carcinoma.
With avelumab now approved for MCC, what treatment options are available to patients not responding to checkpoint inhibitors? Read my thoughts on a promising new approach.
Experts review current data on immunotherapies and provide their perspectives on optimal management of patients with metastatic Merkel cell carcinoma.
In this downloadable slideset, distinguished faculty members Paul Nghiem, MD; Shailender Bhatia; MD, Sandra P. D’Angelo, MD; and Evan J. Lipson, MD, review key data and current practice changes in the treatment of advanced MCC. For additional in-depth analysis of the slideset, please review the accompanying CME-certified text module.
In this downloadable resource, expert faculty Paul Nghiem, MD reviews the rationale for and key data supporting the use of immune checkpoint inhibitors in the treatment of MCC. For additional in-depth analysis, please review the accompanying CME-certified text module, downloadable slides, and ClinicalThought commentaries, as well as our interactive algorithm tool for expert guidance with managing immune-related adverse events.
Use this newly updated Interactive Algorithm Tool to receive expert guidance from Jeffrey S. Weber, MD, PhD, on how to manage immune-related adverse events for your patients receiving immune checkpoint inhibitors, based on the organ system affected and the severity of the event.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.